Literature DB >> 3298305

Glomerular filtration rate is increased in man by the infusion of both D,L-3-hydroxybutyric acid and sodium D,L-3-hydroxybutyrate.

P Fioretto, R Trevisan, M Velussi, A Cernigoi, C De Riva, M Bressan, A Doria, N Pauletto, P Angeli, C De Donà.   

Abstract

A high glomerular filtration rate (GFR) is often found early in insulin-dependent diabetes mellitus (IDDM). It has been suggested that high circulating glucose, glucagon, and GH levels could play a role in this increase in GFR. On the other hand, patients with IDDM in poor metabolic control also have high circulating ketone body levels. This study was undertaken to determine whether exogenous D,L-3-hydroxybutyric acid at two infusion rates (40 and 30 mumol kg-1 min-1) for 180 min altered renal plasma flow (RPF), GFR, and the excretion rate of total protein, beta 2-microglobulin, and albumin in 11 normal (N) subjects and 11 IDDM patients in whom euglycemia was achieved and maintained using the insulin-glucose clamp technique. RPF and GFR were measured by a priming-continuous infusion of [125I]hippurate and [51Cr]EDTA, respectively. The 40 mumol kg-1 min-1 D,L-3-hydroxybutyric acid infusion increased RPF and GFR in both N and IDDM subjects. Mean RPF increased from 588 +/- 78 (+/- SD) to 706 +/- 129 mL min-1 1.73 m-2 in N and from 671 +/- 101 to 781 +/- 99 in IDDM. GFR increased from 121 +/- 11 to 151 +/- 15 ml min-1 1.73 m-2 in N and from 136 +/- 11 to 191 +/- 16 in IDDM. The filtration fraction also was significantly higher in IDDM than in N during the D,L-3-hydroxybutyric acid infusion. The 30 mumol kg-1 min-1 D,L-3-hydroxybutyric acid infusion increased RPF and GFR to a somewhat lesser extent in both groups. D,L-3-hydroxybutyric acid infusions increased the tubular reabsorption rate of ketone bodies and sodium. The increase in tubular sodium reabsorption rate was correlated significantly to that in the tubular ketone body reabsorption rate. A significant decrease in urinary pH was found during the D,L-3-hydroxybutyric acid infusion. D,L-3-Hydroxybutyrate sodium salt (30 mumol kg-1 min-1) also was infused in 5 of the 11 diabetic patients. A similar increase in GFR and RPF occurred. Both total protein and beta 2-microglobulin, but not albumin, excretion rates increased during D,L-3-hydroxybutyric acid (40 mumol kg-1 min-1) infusion in N and IDDM subjects. D,L-3-Hydroxybutyric acid infusion did not change plasma glucagon, GH, or renin activity.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3298305     DOI: 10.1210/jcem-65-2-331

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Diabetic ketosis during hyperglycemic crisis is associated with decreased all-cause mortality in patients with type 2 diabetes mellitus.

Authors:  Ivan Kruljac; Miroslav Ćaćić; Petra Ćaćić; Vedran Ostojić; Mario Štefanović; Aljoša Šikić; Milan Vrkljan
Journal:  Endocrine       Date:  2016-09-03       Impact factor: 3.633

2.  Impaired response to angiotensin II in type 1 (insulin-dependent) diabetes mellitus. Role of prostaglandins and sodium-lithium countertransport activity.

Authors:  P Fioretto; M Sambataro; M G Cipollina; E Duner; C Giorato; A Morocutti; F Mollo; G P Ben; A Carraro; D Sacerdoti
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

Review 3.  Mitochondrial dysfunction in diabetic kidney disease.

Authors:  Josephine M Forbes; David R Thorburn
Journal:  Nat Rev Nephrol       Date:  2018-02-19       Impact factor: 28.314

4.  Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study.

Authors:  Lars C Gormsen; Mads Svart; Henrik Holm Thomsen; Esben Søndergaard; Mikkel H Vendelbo; Nana Christensen; Lars Poulsen Tolbod; Hendrik Johannes Harms; Roni Nielsen; Henrik Wiggers; Niels Jessen; Jakob Hansen; Hans Erik Bøtker; Niels Møller
Journal:  J Am Heart Assoc       Date:  2017-02-27       Impact factor: 5.501

5.  Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients.

Authors:  Roni Nielsen; Niels Møller; Lars C Gormsen; Lars Poulsen Tolbod; Nils Henrik Hansson; Jens Sorensen; Hendrik Johannes Harms; Jørgen Frøkiær; Hans Eiskjaer; Nichlas Riise Jespersen; Søren Mellemkjaer; Thomas Ravn Lassen; Kasper Pryds; Hans Erik Bøtker; Henrik Wiggers
Journal:  Circulation       Date:  2019-04-30       Impact factor: 29.690

6.  14-Day Ketone Supplementation Lowers Glucose and Improves Vascular Function in Obesity: A Randomized Crossover Trial.

Authors:  Jeremy J Walsh; Helena Neudorf; Jonathan P Little
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.